Sunshine Biopharma Warrant Stock Today
| SBFMW Stock | USD 0.17 0.04 19.05% |
Performance11 of 100
| Odds Of DistressOver 71
|
Sunshine Biopharma is selling for under 0.17 as of the 29th of November 2024; that is 19.05 percent down since the beginning of the trading day. The stock's lowest day price was 0.17. Sunshine Biopharma has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Sunshine Biopharma Warrant are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of February 2022 | Category Healthcare | Classification Health Care |
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada. Sunshine Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. More on Sunshine Biopharma Warrant
Moving against Sunshine Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Sunshine Stock Highlights
| President Chairman | Steve Slilaty | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sunshine Biopharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sunshine Biopharma's financial leverage. It provides some insight into what part of Sunshine Biopharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sunshine Biopharma Warrant (SBFMW) is traded on NASDAQ Exchange in USA. It is located in 333 Las Olas Way, Fort Lauderdale, FL, United States, 33301 and employs 44 people. Sunshine Biopharma is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Sunshine Biopharma Warrant has accumulated about 40.56 M in cash with (8.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sunshine Biopharma Probability Of Bankruptcy
Sunshine Biopharma Historical Income Statement
Sunshine Stock Against Markets
Sunshine Biopharma Corporate Executives
Elected by the shareholders, the Sunshine Biopharma's board of directors comprises two types of representatives: Sunshine Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sunshine. The board's role is to monitor Sunshine Biopharma's management team and ensure that shareholders' interests are well served. Sunshine Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sunshine Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Camille Sebaaly | CFO Secretary | Profile |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.